Jiangsu Bioperfectus Technologies Co Ltd (688399) — Cash Flow-to-Debt Ratio
Jiangsu Bioperfectus Technologies Co Ltd (688399) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CN¥20.00 Million could theoretically repay 0% of its total liabilities (CN¥681.04 Million) in one year. See Jiangsu Bioperfectus Technologies Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Bioperfectus Technologies Co Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Jiangsu Bioperfectus Technologies Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Jiangsu Bioperfectus Technologies Co Ltd.
Annual Cash Flow-to-Debt Ratio for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)
Year-by-year debt coverage analysis for Jiangsu Bioperfectus Technologies Co Ltd. Check earnings quality score of Jiangsu Bioperfectus Technologies Co Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.30x | CN¥145.93 Million | CN¥489.32 Million | ▲ +232.1% |
| 2023 | -0.23x | CN¥-113.14 Million | CN¥501.31 Million | ▼ -112.8% |
| 2022 | 1.77x | CN¥1.96 Billion | CN¥1.11 Billion | ▲ +72.5% |
| 2021 | 1.02x | CN¥985.52 Million | CN¥962.89 Million | ▼ -32.9% |
| 2020 | 1.53x | CN¥935.88 Million | CN¥613.18 Million | ▲ +91.0% |
| 2019 | 0.80x | CN¥106.72 Million | CN¥133.57 Million | ▼ -33.5% |
| 2018 | 1.20x | CN¥85.82 Million | CN¥71.46 Million | ▼ -1.8% |
| 2017 | 1.22x | CN¥61.59 Million | CN¥50.37 Million | ▲ +88.7% |
| 2016 | 0.65x | CN¥22.09 Million | CN¥34.09 Million | — |